Cargando…
Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
Bone metastatic breast cancer is currently incurable and will be evident in more than 70% of patients that succumb to the disease. Understanding the factors that contribute to the progression and metastasis of breast cancer can reveal therapeutic opportunities. Matrix metalloproteinases (MMPs) are a...
Autores principales: | Tauro, Marilena, Lynch, Conor C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025260/ https://www.ncbi.nlm.nih.gov/pubmed/29874869 http://dx.doi.org/10.3390/cancers10060185 |
Ejemplares similares
-
Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment
por: Shay, Gemma, et al.
Publicado: (2017) -
Cutting to the chase: How pathogenic mutations cause Alzheimer’s
por: Wolfe, Michael S.
Publicado: (2015) -
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy
por: Laghezza, Antonio, et al.
Publicado: (2020) -
Commentary: Cut to the chase: It's a matter of principle
por: Romano, Matthew A.
Publicado: (2021) -
Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases
por: Marquart, Mary E.
Publicado: (2021)